FDA on Monday released a proposal that would ease access to unapproved medications for certain patients and allow pharmaceutical companies to charge patients for the drugs in some cases, the Washington Post reports (Stein, Washington Post, 12/12). Since the 1970s, FDA has made experimental drugs available to individuals or groups of patients under compassionate-use programs. [click link for full article]
More...